Get started
Author

Elisa Fernández-Fernández

Observed names: E Fernandez, E. Fernández, E. Fernández Fernández, E. Fernández-Fernández, Elisa Fernandez-Fernandez, Elisa Fernández, Elisa Fernández Fernández, Elisa Fernández-Fernandez, Fernandez E, e. fernández-fernández
ORCID: 0000-0002-1628-5042
Observed ORCID: 0000-0002-1628-5042
OpenAlex ID: A5004969875
False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign
2019 · Elisa Fernández-Fernández, Irene Monjo-Henry, et al. · Rheumatology · 75
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
2023 · Juan Molina-Collada, Isabel Castrejón, et al. · RMD Open · 39
PDF
Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports
2019 · O. Lamy, E. Fernández-Fernández, et al. · Osteoporosis International · 35
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification
2022 · Marta Novella-Navarro, Virginia Ruiz-Esquide, et al. · Clinical and Experimental Rheumatology · 28
Positive ultrasound halo sign of temporal arteries due to amyloidosis
2019 · Juan Molina Collada, Elena Ruíz Bravo-Burguillos, et al. · Rheumatology · 24
Diagnostic validity of ultrasound including extra-cranial arteries in giant cell arteritis
2022 · Irene Monjo Henry, E. Fernández Fernández, et al. · Clinical Rheumatology · 19
The OMERACT giant cell arteritis ultrasonography score: a potential predictive outcome for assessing the risk of relapse during follow-up
2024 · Juan Molina-Collada, Irene Monjo-Henry, et al. · Rheumatology · 17
PDF
Validity of the EULAR recommendations on the use of ultrasound in the diagnosis of giant cell arteritis
2022 · Elisa Fernández-Fernández, Irene Monjo, et al. · RMD Open · 17
PDF
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry
2024 · Juan Molina-Collada, Marta Domínguez-Álvaro, et al. · Rheumatology · 16
Influence of rheumatoid factor on serum drug levels of tumour necrosis factor inhibitors with different structures in rheumatoid arthritis
2023 · Ana Martínez-Feito, Chamaida Plasencia-Rodríguez, et al. · Clinical and Experimental Rheumatology · 15
Multiple vertebral fractures following discontinuation of denosumab treatment: ten clinical cases report
2020 · Elisa Fernández Fernández, Diego Benavent Núñez, et al. · Reumatología Clínica (English Edition) · 14
Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis
2023 · Irene Monjo-Henry, Elisa Fernández-Fernández, et al. · Arthritis Research & Therapy · 13
PDF
Fracturas vertebrales múltiples tras la suspensión de tratamiento con denosumab: serie de diez casos
2019 · Elisa Fernández Fernández, Diego Benavent Núñez, et al. · Reumatología Clínica · 13
Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis
2024 · Irene Monjo-Henry, Mariela Uyaguari, et al. · Rheumatology · 12
Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis: comparative study with FDG-PET/CT
2023 · Juan Molina-Collada, Isabel Castrejón, et al. · RMD Open · 12
PDF
Op0210 False Positives of Ultrasound in Giant Cell Arteritis. Some Diseases Can Also Have Halo Sign
2019 · Elisa Fernández, Irene Monjo, et al. · Annals of the Rheumatic Diseases · 10
PDF
Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry
2025 · Adrián Martín-Gutiérrez, Juan Molina-Collada, et al. · Rheumatology · 9
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis
2024 · Marta Novella-Navarro, Virginia Ruiz-Esquide, et al. · Clinical Rheumatology · 9
Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
2023 · Marta Novella -Navarro, JoséLuis Cabrera-Alarcón, et al. · RMD Open · 8
PDF
Different giant cell arteritis phenotypes may present distinct types of ischaemic complications
2024 · Helena M. Amar Muñoz, Juan Molina-Collada, et al. · Clinical and Experimental Rheumatology · 6
PDF
Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry
2025 · Delia Fernández-Lozano, Marta Domínguez-Álvaro, et al. · Rheumatology · 5
Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry
2025 · Juan Molina-Collada, Lucía Otero-Varela, et al. · Rheumatology · 5
Op0180 Diagnostic Validity of Ultrasound Including Extra-cranial Arteries in Giant Cell Arteritis
2020 · I. Monjo, E. Fernández, et al. · Annals of the Rheumatic Diseases · 4
PDF
Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry
2025 · Gastón A. Ghio, Marta Domínguez-Álvaro, et al. · Nutrients · 2
PDF
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry
2025 · Juan Molina-Collada, Marta Domínguez-Álvaro, et al. · Arthritis Research & Therapy · 2
PDF
Works count: 55
Citation count: 426
H-index: 12
I10-index: 16
Year
Topic
Type